Skip to content
88
Categories
Satellite Symposium
Satellite Symposium
Satellite Symposium

Focus on QoL and tolerability in CML-CP: Status, limitations and latest advances

- , Kairo 1-2

Schedule Slot

Focus on QoL and tolerability in CML-CP: Status, limitations and latest advances

88
Categories
Satellite Symposium
Satellite Symposium
Satellite Symposium

Focus on QoL and tolerability in CML-CP: Status, limitations and latest advances

- , Kairo 1-2

Endorsed by: Novartis Pharma Schweiz AG

Chair:
Stefan Balabanov (Universitätsspital Zürich)

  1. Welcome & Introduction

    Presentation time:
    5 min

    Chair: Stefan Balabanov (Universitätsspital Zürich)

  2. Review of QoL situation and recent advances

    Presentation time:
    15 min

    Speaker: Daniela Žáčková (Masaryk University)

  3. QoL & tolerability updates from phase III study ASC4FIRST

    Presentation time:
    20 min

    Speaker: Jakob Passweg (Basel University Hospital)

  4. QoL & tolerability updates from phase III study ASC4START

    Presentation time:
    10 min

    Speaker: Natalia Baran (Inselspital)

  5. Panel Discussion and Q&A

    Presentation time:
    10 min

    Chair: Stefan Balabanov (Universitätsspital Zürich)